Concepedia

Rachel Abbotts

RA

Statistics

Publications

10

Citations

780

H-Index

10

Active since

2010

Affiliations

University of Nottingham(Current)

Nottingham University Hospitals NHS Trust

National Institute on Aging

Nottingham Trent University

National Institutes of Health

Rachel Abbotts is an author at University of Nottingham specializing in molecular oncology, oncology, and dna repair.

ORCID

Publications per year

2010–2021

10

Publications

10

Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

Tarek M. Abdel-Fatah, Roslin Russell, Nada Albarakati et al. · Molecular Oncology · 2014 · 149 citations · Full text

, , +17

Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers

Ahmad Al‐Attar, Lucy Gossage, Khaleel Fareed et al. · British Journal of Cancer · 2010 · 111 citations · Full text

, , +17

DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation

Rachel Abbotts, Michael J. Topper, Christopher Biondi et al. · Proceedings of the National Academy of Sciences · 2019 · 103 citations · Full text

, , +17

Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy

Rebeka Sultana, Tarek M.A. Abdel-Fatah, Rachel Abbotts et al. · Cancer Research · 2012 · 100 citations

, , +17

Synthetic lethal targeting of DNA double‐strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors

Rebeka Sultana, Daniel R. McNeill, Rachel Abbotts et al. · International Journal of Cancer · 2012 · 94 citations · Full text

, , +17

1–5 of 10